You are here

Muscle Spasticity Treatment Market Growth and Current Trend Status, Segmentation, Forecast 2030

Market Dynamics:
The global market for treating muscle spasticity demonstrated significant strength in 2021 and is poised to exhibit a rapid revenue compound annual growth rate (CAGR) throughout the forecast period. The increasing prevalence of musculoskeletal disorders worldwide, encompassing over 150 different conditions affecting muscles, bones, joints, and nearby connective tissues, resulting in temporary or permanent limitations in functioning and participation, is a key driver. However, the market growth may be constrained by the serious adverse effects associated with muscle spasticity treatment medications and the lack of awareness about the condition.
Spasticity, a motor disease characterized by tightness or stiffness, is marked by a velocity-dependent increase in muscle tone or tonic stretch reflexes associated with hypertonia.
Get a sample copy of the Muscle Spasticity Treatment Market report:

Factors Supporting Market Growth:

There are several factors that contribute to the growth in revenue within the market for muscle spasticity. Spasticity impacts a significant portion of individuals across various conditions such as stroke, cerebral palsy (CP), traumatic brain injury (TBI), spinal cord injury (SCI), and multiple sclerosis (MS). According to the Global Burden of Disease 2019 data, there is a notable global burden of muscle-related disorders, including rheumatoid arthritis, osteoarthritis, low back pain, neck discomfort, fractures, and other injuries, affecting approximately 1.71 billion individuals worldwide. Musculoskeletal issues affect people of all age groups, with low back pain being prevalent in 570 million cases globally. Furthermore, the elderly population is particularly vulnerable to muscle spasticity due to their weakened immune systems, which further drives market growth.
Clinicians and patients are encouraged to prioritize non-pharmacological treatments for muscle spasticity, such as home exercises and interdisciplinary rehabilitation procedures, which may impede the revenue growth of the treatment market. Various physical modalities and treatments, including direct tendon pressure, splinting, serial casting, heat and cold modalities, functional electrical stimulation, vibration, and biofeedback, should be considered. The use of pharmacological treatments is associated with side effects, potentially limiting market growth.
High-income nations, the WHO Western Pacific Region, and the WHO South-East Asia Region are among the most affected regions, totaling approximately 1.24 billion people. The rise in research and development activities focused on pharmaceuticals for symptomatic muscle spasticity treatment is driving market expansion. Institutional initiatives to collaborate with major corporations for muscle spasticity research are expected to boost market revenue growth.
Geographic Market Scenario:
Largest Market Share:
North America is anticipated to hold the largest revenue share during the forecast period. This can be attributed to the introduction of new treatment options, increased healthcare expenditures, availability of treatment choices, and rising awareness of the disease in the region.
Fastest Growing Region:
Asia Pacific is expected to witness significant revenue growth, driven by a considerable increase in the geriatric population in countries like China and India, as well as the presence of generic manufacturers and the expansion of healthcare facilities.
Key Market Trends and Innovations:
Clinical trials for muscle selection and botulinum toxin effect treatment results for post-stroke elbow flexor spasticity have been conducted. Additionally, injections of human recombinant hyaluronidase are being tested in a single-center, double-blind, randomized, placebo-controlled, crossover Phase II trial on individuals with stiff upper limb muscles after a stroke.
Competitive Landscape:
Organic and inorganic strategies are being adopted by market players. For instance, in July 2021, the U.S. Food and Drug Administration (FDA) approved a label expansion for AbbVie’s Botox to include eight new muscles for the treatment of upper limb spasticity in adults.
Major Companies in the Market Include:
• Eli Lilly and Company
• Flexion Therapeutics
• Ipsen Pharma
• Allergan
• Acorda Therapeutics, Inc.
• Merz Pharma
• Beximco Pharmaceuticals Ltd.
• Hoffmann-La Roche Ltd.
• Novartis
• Sun Pharmaceuticals
• Teva Pharmaceutical Industries
Report Offerings and Superiority:
The report provides historical data, forecasts, and revenue growth analysis at a global, regional, and country level, along with industry trends, consumption pattern details, and competitive landscape analysis. Additionally, it offers insights into industry trends, drivers, restraints, opportunities, threats, market strategies, segment revenue, and revenue share contribution by each regional and country market. Furthermore, the report includes company financials and impact analysis.
End-Use Outlook:
• Hospital Pharmacies
• Retailer Pharmacies
• Online Pharmacy Stores
Distribution Channel Outlook:
• Offline
• Online
Treatment Outlook:
• Diazepam
• Botulinum Toxin
• Dantrolene Sodium
• Tizanidine
• Baclofen
• Others
Route of Administration Outlook:
• Oral
• Parenteral
• Others
Drug Type Outlook:
• Prescription Drugs
• Over-the-Counter Drugs
Dosage Form Outlook:
• Tablets
• Injections
Regional Outlook:
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa
Explore Trending Reports:
Pressure Sensitive Adhesives Market-
Construction Adhesive Market-
Basalt Fiber Market-
Ammonium Nitrate Market-
Roofing Systems Market-
Polyimide Films Market-
Plastic Fasteners Market-
Request a customization of the report:
Thank you for reading our report. To know more about the customization or any query about the report contents, please connect with us and our team will ensure the report is tailored to meet your requirements.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyse consumer behaviour shifts across demographics, across industries, and help clients to make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Products, and Energy. We consistently update our research offerings to ensure our clients are aware of the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise. Our industry experience and ability to develop a concrete solution to any research problems provides our clients with the ability to secure an edge over their respective competitors.
Contact Us:
John W
(Head of Business Development)
Reports and Data | Web:
Direct Line: +1-212-710-1370
Blogs | Press Release | Industry News | Our competencies
Browse More Upcoming Reports @
Browse More Latest Reports @
Browse Latest Blogs:
Browse Latest Press Release: